Tag: Massachusetts

Biden tests positive for COVID-19, has ‘very mild symptoms’

Tina Marie (Ms. Cat)

By ZEKE MILLER and CHRIS MEGERIAN, Associated Press

WASHINGTON (AP) — President Joe Biden tested positive for COVID-19 on Thursday and is experiencing “very mild symptoms,” the White House said, as new variants of the highly contagious virus are challenging the nation’s efforts to get back to normal after two and a half years of pandemic disruptions.

Biden tests positive for COVID-19, has ‘very mild symptoms’

Various Coronavirus News Updates: U.S. National Emergency extended, Bill Gates disappointed, IVM, breakthrough cases, immunity + antibodies.

Tina Marie (Ms. Cat)

Biden to extend U.S. national emergency due to COVID-19 health risk

Bill Gates is Ready to Capitalize on ‘The Next Pandemic’

Estimated 73% of US now immune to omicron: Is that enough?

Arkansas county praises doctor who gave inmates ivermectin

2,044 Fully Vaccinated Indiana Residents Died Of COVID-19; 329,000 Breakthrough Cases Recorded

A test to determine COVID immunity could reshape US policy

I’m behind because I haven’t really been keeping up with coronavirus news. Out of sight, out of mind! 🤷🏼‍♀️

Pfizer CEO to Public: Just ‘Trust’ Us on the Covid Booster

Tina Marie (Ms. Cat)

Pfizer CEO to Public: Just Trust Us on the Covid Booster

Pfizer announced its global phase 3 trial on a third dose in mid-July. That trial’s completion date is in 2022. Phase 3 results generally are required before regulatory approval.

“We are confident in this vaccine and the third dose, but you have to remember the vaccine efficacy study is still going on, so we need all the evidence to back up that,” Jerica Pitts, Pfizer’s director of global media relations, said Monday. The financial stakes are enormous: Pfizer announced in July that it expects $33.5 billion in covid-19 vaccine revenue this year.

…

The White House has added to the mixed messaging: Spokesperson Jen Psaki confirmed that the U.S. will buy an additional 200 million doses of the Pfizer-BioNTech vaccine for inoculating children under 12 and for possible boosters.